Topical JAK and PDE4 Inhibitors Appear Promising for Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis
J Dermatol 2021 Sep 06;[EPub Ahead of Print], L Zhang, D Du, L Wang, L Guo, X JiangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.